EFIM Fellowhip - relaunched
EFIM is delighted to relaunch the Fellowship programme which is designed for all members of EFIM national societies who want to be part of a global community that share the same vision.
EFIM Fellowship is a professional credential that recognises and rewards physicians for their outstanding achievements, and contribution to internal medicine and the community.
To find how to become EFIM Fellow please visit EFIM Fellowship page here.
EFIM Annual Report 2020
EFIM is delighted to present the information to EFIM National Societies Members and the wider public on the activities of the Federation during 2020 in the Annual Report.
EFIM 2020 annual report highlights the Federation's most significant achievements in 2020.
Read here EFIM 2020 Annual Report.
EFIM has joined European Alliance for Value in Health
Today, EFIM joined the 11 associations to form the European Alliance for Value in Health in order to connect different stakeholders to create conditions and inspire others. The Alliance represents a broad group of European associations representing patients, scientific and professional societies, healthcare managers, hospitals, regional health authorities and life-science industries. We are in a pivotal moment for European health systems, when the COVID-19 pandemic has put health systems under severe stress and added to the already existing pressures stemming from ageing populations and chronic diseases.
EBIM launched the Educational Platform
We are pleased to inform you that the European Board of Internal Medicine, EBIM a joint collaboration between EFIM and the UEMS Section of Internal Medicine launched the Educational Platform online.
Access here the EBIM website: https://www.ebim-online.org/ .
EBIM is committed to advancing postgraduate education in internal medicine in Europe through guidance on the standardisation of training and practice of internal medicine within Europe for the benefit of patient care.
You can read more in the latest newslettes published by EBIM:
Overdiagnosis and Low Value Healthcare Webinar
We are pleased to invite you to register to the upcoming Webinar on Overdiagnosis and Low Value Healthcare organised by the EFIM Choosing Wisely.
To connect to the webinar on 12 October please click on the Zoom link below:
https://zoom.us/j/4776343293
To follow the Special presentation (Choosing Wisely International Roundtable) by Prof. Don Berwick on 13 October please make sure you register to the link below:
Physicians' Codex - DGIM
The medical profession is facing increasing pressure to adapt its patient care to optimize the economic benefit for hospitals and practices.
EFIM YI Webinar - Headache: Clinical approach and management of patients with headaches within Acute Internal and Emergency Medicine
The Young Internists section of EFIM hosted the webinar “Headache: Clinical approach and management of patients with headaches within Acute Internal and Emergency Medicine on Monday, 14 September f. The webinar ws presented by Prof. Ben Lovel from UK, from UK, an Associate Professor of Medical Education and a consultant in Acute Internal Medicine at University College Hospital, where he is also the postgraduate lead for Acute Medicine.
View the webinar via EFIM You Tube channel on the link below:
https://youtu.be/hnPyxADPkyk
EFIM General Assembly
Dear EFIM Members,
We are pleased to inform you that the next General Assembly will be organised virtually via the Zoom platform on Friday, 25 September 2020.
Please register on the link below to attend the next General Assembly.
https://us02web.zoom.us/webinar/register/WN_QDA1oMBFTLi4KKOaviQNHQ
We are looking forward to talking to you in September!
IMAGINE the future - a voice of young internists - JAMA
We are pleased to inform you that EFIM IMAGINE Working Group published their paper "IMAGINE the future - a voice of young internists" in JAMA under the title "Sex, Gender, and Precision Medicine". Article can be accessed via JAMA website.
Tocilizumab in COVID-19 - Which Clinical Benefits?
Tocilizumab is a recombinant humanized monoclonal IL-6 receptor antibody indicated for the treatment of severe rheumatoid arthritis and other inflammatory disorders.Following clinical observation from China, a series of Italian studies have been carried out to evaluate the off-label use of tocilizumab in COVID-19 patients.
The European Journal of Internal Medicine (EJIM) has recently accepted for publication three articles on the off-label use of tocilizumab in patients with severe COVID-19.